Dr. Melanie Elizabeth Townsend, MD

Dr. Townsend practices at AdventHealth Orlando in Orlando, Florida, part of AdventHealth.

Dr. Townsend's NPI, 1922447952, was assigned on June 24, 2013. Dr. Townsend graduated from Indiana University School Of Medicine in 2013. Dr. Townsend holds Kentucky license TP654.

Dr. Townsend's primary practice is AdventHealth Orlando, at 601 E Rollins St, Orlando, FL 32803 in Orange County. The practice phone is (407) 303-1976.

Dr. Townsend's primary practice is AdventHealth Orlando in Orlando, Florida, part of AdventHealth. Dr. Townsend is also affiliated with UofL Health - UofL Hospital. The medical group on file is AdventHealth Medical Group. Dmand AI also links Dr. Townsend to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Townsend practices, 3 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Townsend's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Townsend is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Townsend's licenses on file in 3 states: Kentucky, Florida and Missouri.

Dmand AI lists acute sinusitis, larynx and vocal cord disease and thyroid surgery among the conditions Dr. Townsend treats.

CMS data shows 255 Medicare services from Dr. Townsend across 5 procedure codes in 2024, for 180 Medicare patients. Medicare paid $20,013 for them. Every service was in an office.

CMS counts 180 Medicare patients who saw Dr. Townsend in 2024. The largest group is 65 to 74, with 82 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Townsend's median patient age at 69, with 52% women.

In 2024, Dr. Townsend wrote 407 Medicare Part D claims for 131 patients. 92% of them were for generic drugs. CMS names the drug for 205 of them, across 10 drugs with 11 or more claims each, at $2,354 in total drug cost. In 2023, CMS named 184 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Townsend for performance year 2024, reported as part of a group. Dr. Townsend accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 18 procedures of melanoma (skin cancer) excision by Dr. Townsend, more than 73% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Townsend, published from 2016 to 2024. The most frequent topics are Carcinoma, Squamous Cell and Patient Care Team. Dr. Townsend has published most often in JAMA Otolaryngol Head Neck Surg. Dr. Townsend's most frequent co-authors are Brian Nussenbaum, MD, William Greer Albergotti, MD and Neel Kishor Bhatt, MD.

CMS Open Payments shows 64 general payments to Dr. Townsend from 22 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 45% of the total. Biogen, Inc. paid the most, $3,174.

Dr. Townsend graduated from Indiana University School Of Medicine in 2013.

Dr. Townsend is in network with 16 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.